Definitive Contract 75N93023C00039
Award Date 9/1/23
Potential Completion Date 8/31/26
Potential Value $750K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Irwindale, CA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
13
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $600,000 firm fixed price contract was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Silver Lake Research Corporation, doing business as Silver Lake Research Corp., for EAP-derived monoclonal antibodies for phenotyping guinea pig immune cells under Phase I of the Small Business Innovation Research (SBIR) program for fiscal year 2020. As a total small business set-aside, the contract supports Silver Lake's research and development...
- This is a $599,999.40 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases to Silver Lake Research Corporation, doing business as Silver Lake Research Corp. The contract is for the development of EAP-derived monoclonal antibodies for phenotyping immune cells of animal models of disease. This work supports infectious disease research and response programs. The contract does not have a...
- Silver Lake Research Corporation, doing business as Silver Lake Research Corp., has been awarded a firm fixed price definitive contract valued at $600,000 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this contract, Silver Lake will deliver EAP-derived monoclonal antibodies for immune targets involved in cell activation in hamsters, as requested in the original solicitation. The prime contractor will perform work in Irwindale, California....
- The Department of Homeland Security Science and Technology Directorate awarded a firm-fixed-price contract valued at $1,656,989.53 to Silver Lake Research Corporation, a for-profit organization and manufacturer of goods, for the rapid detection of high-priority foreign animal pathogens using enzyme-linked immunosorbent assay (ELISA)-derived hyperspecific monoclonal antibodies. This contract, which does not have a set-aside designation, is for the development of rapid testing innovations,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price definitive contract valued at $585,999.00 to Protein Innovation Labs, Inc., a small business concern, for the provision of reagents to support immunologic analysis of non-mammalian models. This contract was awarded under the National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) Small Business Innovation...
- This $596,519 fixed-price federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Ampersand Biosciences LLC, a woman-owned small business. The contract is for the development of reagents to support immunologic analysis of non-mammalian and underrepresented mammalian models, such as ferrets and mice, under SBIR Topic 107. This aligns with NIAID's mission to conduct and support research to...
- This is a Definitive Contract awarded by the Centers for Disease Control and Prevention (CDC) to Silver Lake Research Corporation, a small business manufacturer of rapid testing innovations. The $466,200 Firm Fixed Price contract is for the development of "HYPERSPECIFIC MONOCLONAL ANTIBODIES AND LATERAL FLOW ASSAYS" and does not have a set-aside designation. Silver Lake Research Corporation is also the recipient of prime federal contracts and grants from agencies such as the National...
- This is a Small Business Innovation Research (SBIR) contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Luna Labs USA LLC, a subsidiary of Luna Innovations Incorporated. The $599,993.00 firm fixed-price contract is for developing "Reagents for Immunologic Analysis of Non-Mammalian and Underrepresented Mammalian Models." This SBIR contract is set aside for small businesses and supports NIAID's mission...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1.08 million firm fixed-price definitive contract to Ampersand Biosciences LLC, a woman-owned small business biotechnology firm based in Lake Clear, New York, for further characterization and validation of monoclonal antibodies to study respiratory diseases. The contract, awarded on September 30, 2024, with an ultimate completion date of September 29, 2026, represents NIAID's continued investment in developing...
- This is a $600,000.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Glycoscientific, L.L.C., a small business concern. The contract is for the development of reagents for immunologic analysis of non-mammalian and underrepresented mammalian models, under the Small Business Innovation Research (SBIR) program. The contract has a period of performance ending on November 23,...